From Screening to Support: A Multi-Method Analysis of HRSN Integration in Cancer Care (NCT07352579) | Clinical Trial Compass
RecruitingNot Applicable
From Screening to Support: A Multi-Method Analysis of HRSN Integration in Cancer Care
United States500 participantsStarted 2025-12-11
Plain-language summary
This observational study aims to identify the factors that influence whether cancer patients accept or decline supportive care services after screening positive for health-related social needs (HRSNs) at the Sidney Kimmel Comprehensive Cancer Center.
The study focuses on adult oncology patients who previously reported at least one HRSN-such as transportation, food, housing, or utility needs-but declined assistance when it was offered.
The main questions it aims to answer are:
* What factors shape cancer patients' intentions to use supportive care services for HRSNs?
* Why do patients who screen positive for HRSNs choose not to accept help offered by the healthcare system?
Participants will:
* Complete a one-time electronic survey delivered via MyChart or email.
* Optionally participate in a semi-structured Zoom interview (for a subset of 20-30 survey respondents) to explore decision-making in greater depth.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Individuals must meet all of the following inclusion criteria in order to be eligible to participate in the study:
* Provide informed consent via check box for survey
* Provide verbal consent via Zoom for interview
* Must be able to read and understand English
* Willing to comply with all study procedures and be available for the duration of the study
* Patients with existing HRSN data in their EHR that answere4d yes to risk in at least one domain and no to wanting help/follow up
Exclusion Criteria:
* An individual who meets any of the following criteria will be excluded from participation in this study:
* If they do not consent
* Non-patients with existing HRSN data in their EHR
* Individuals unable to complete the survey due to language barriers or other cognitive limitations
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Factors influencing cancer patients' intent to use oncology supportive care for HRSNs